Skip to main content

Table 1 The Socio-demographic and baseline characteristics in IPT and non IPT cohorts in Dilla University Referral Hospital

From: Effect of isoniazid preventive therapy on tuberculosis or death in persons with HIV: a retrospective cohort study

Baseline covariates Non IPT cohort IPT cohort Total
N = 1548 N = 374 N = 1922
No. (%) No. (%) No. (%)
Gender Female 848 (54.8) 225 (11.768.2) 1073 (55.8)
Age group 15 – 25 years 333 (21.5) 78 (20.9) 411 (21.4)
26 – 29 years 238 (15.4) 63 (16.8) 301 (15.7)
30 – 34 years 355 (22.9) 94 (25.1) 449 (23.4)
35 – 39 years 268 (17.3) 58 (15.5) 326 (17.0)
40 – 99 years 354 (22.9) 81 (21.7) 435 (22.6)
ART at baseline No 1307 (84.4) 328 (87.7) 1635 (85.1)
Yes 241 (15.6) 46 (12.3) 287 (14.9)
Cotrimoxazole (ever use)* Yes 1290 (83.3) 341 (91.2) 1631 (84.9)
WHO stage of HIV disease* Stage I 141 (9.1) 39 (10.4) 180 (9.4)
Stage II 247 (16.0) 78 (20.9) 325 (16.9)
Stage III 1000 (64.6) 236 (63.1) 1236 (64.3)
Stage IV 160 (10.3) 21 (5.6) 181 (9.4)
WHO functional status* Ambulatory 590 (38.1) 110 (29.4) 700 (36.4)
Bedridden 99 (6.4) 8 (2.1) 107 (5.6)
Working 859 (55.5) 256 (68.4) 1115 (58.0)
CD4* 0 – 99 cells/mm3 477 (30.8) 76 (20.3) 553 (28.8)
100 – 199 cells/mm3 561 (36.3) 142 (38.0) 703 (36.6)
200 - 349 cells/mm3 446 (28.8) 145 (38.8) 591 (30.8)
350 + cells/mm3 63 (4.1) 11 (2.9) 74 (3.9)
Body weight < = 50 Kgs. 726 (47.5) 153 (41.6) 879 (46.4)
50-74 Kgs. 763 (50.0) 204 (55.4) 967 (51.0)
75 + Kgs. 38 (2.5) 11 (3.0) 49 (2.6)
Transfer in yes 160 (10.3) 36 (9.6) 196 (10.2)
Point of entry to care (Entry from) Referred from the same hospital 1197 (77.3) 296 (79.1) 1493 (77.7)
Self-referred 29 (1.9) 6 (1.6) 35 (1.8)
Referred from other health facilities 322 (20.8) 72 (19.3) 394 (20.5)
Outcomes Censored 1301 (84.0) 363 (97.1) 1664 (86.6)
TB 105 (6.8) 5 (1.3) 110 (5.7)
Death 142 (9.2) 6 (1.6) 148 (7.7)
Composite outcome TB or death 247 (16.0) 11 (2.9) 258 (13.4)
  1. *:p value < 0.05. ART Antiretroviral therapy, HIV Human Immunodeficiency Virus, IPT Isoniazid Preventive Therapy, N Number of people, TB Tuberculosis, and WHO World Health Organization